Cardlytics, Inc.

For the period ended Mar 31, 2026. Filed May 7, 2026.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Mar 31, 2026 · Filed May 7, 2026

CDLX$1.82-6.7%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Condensed Consolidated Balance Sheets (Unaudited)

(Amounts in thousands, except par value amounts)

	March 31, 2026	December 31, 2025
Assets
Current assets:
Cash and cash equivalents	$35,673	$48,719
Marketable securities	24,130	—
Accounts receivable and contract assets, net	63,076	82,458
Other receivables	2,674	2,474
Prepaid expenses and other assets	2,966	3,213
Current assets of discontinued operations	—	415
Total current assets	128,519	137,279
Long-term assets:
Property and equipment, net	1,743	1,931
Right-of-use assets under operating leases, net	4,403	4,723
Goodwill	110,305	110,305
Capitalized software development costs, net	17,779	19,005
Other long-term assets, net	1,160	1,235
Noncurrent assets of discontinued operations	—	11,163
Total assets	$263,909	$285,641
Liabilities and stockholders' equity
Current liabilities:
Accounts payable	$2,600	$2,655
Accrued liabilities:
Accrued compensation	4,572	6,038
Accrued expenses	9,918	7,125
Partner Share liability	17,470	24,792
Consumer Incentive liability	20,586	32,144
Deferred revenue and other liabilities	2,738	2,541
Current operating lease liabilities	1,467	1,438
Current liabilities of discontinued operations	—	1,657
Total current liabilities	$59,351	$78,390
Long-term liabilities:
Convertible senior notes, net	$169,131	$168,850
Lines of credit	35,070	40,070
Long-term operating lease liabilities	4,360	4,748
Long-term liabilities of discontinued operations	—	91
Total liabilities	$267,912	$292,149
Stockholders’ deficit:
Common stock, $0.0001 par value—100,000 shares authorized and 55,071 and 54,514 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively.	$10	$10
Additional paid-in capital	1,405,063	1,399,542
Accumulated other comprehensive loss	(532)	(1,996)
Accumulated deficit	(1,408,544)	(1,404,064)
Total stockholders’ deficit	(4,003)	(6,508)
Total liabilities and stockholders’ deficit	$263,909	$285,641

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.